These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15569926)
21. [Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer]. Lin Q; Zhuang YZ; Xu DP; Ye JX; Chen PQ Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):246-9. PubMed ID: 12839686 [TBL] [Abstract][Full Text] [Related]
22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
23. An unusual gene dosage effect of p27kip1 in a mouse model of prostate cancer. Abate-Shen C; Shen MM Cell Cycle; 2005 Mar; 4(3):e45-7. PubMed ID: 15701964 [TBL] [Abstract][Full Text] [Related]
24. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer]. Zheng XY; Ding W; Xie LP; Chen ZD Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249 [TBL] [Abstract][Full Text] [Related]
25. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908 [TBL] [Abstract][Full Text] [Related]
26. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Kim MJ; Cardiff RD; Desai N; Banach-Petrosky WA; Parsons R; Shen MM; Abate-Shen C Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2884-9. PubMed ID: 11854455 [TBL] [Abstract][Full Text] [Related]
27. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
28. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337 [TBL] [Abstract][Full Text] [Related]
29. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543 [TBL] [Abstract][Full Text] [Related]
30. Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice. Fedele M; Palmieri D; Chiappetta G; Pasquinelli R; De Martino I; Arra C; Palma G; Valentino T; Pierantoni GM; Viglietto G; Rothstein JL; Santoro M; Fusco A Endocr Relat Cancer; 2009 Jun; 16(2):483-90. PubMed ID: 19261681 [TBL] [Abstract][Full Text] [Related]
31. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1). Turturro F; Frist AY; Arnold MD; Seth P; Pulford K Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142 [TBL] [Abstract][Full Text] [Related]
32. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways. Damo LA; Snyder PW; Franklin DS Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024 [TBL] [Abstract][Full Text] [Related]
33. Pten dose dictates cancer progression in the prostate. Trotman LC; Niki M; Dotan ZA; Koutcher JA; Di Cristofano A; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Van Dyke T; Cordon-Cardo C; Pandolfi PP PLoS Biol; 2003 Dec; 1(3):E59. PubMed ID: 14691534 [TBL] [Abstract][Full Text] [Related]
34. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27 Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462 [TBL] [Abstract][Full Text] [Related]
35. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735 [TBL] [Abstract][Full Text] [Related]
36. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Cunningham JJ; Levine EM; Zindy F; Goloubeva O; Roussel MF; Smeyne RJ Mol Cell Neurosci; 2002 Mar; 19(3):359-74. PubMed ID: 11906209 [TBL] [Abstract][Full Text] [Related]
37. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659 [TBL] [Abstract][Full Text] [Related]
38. Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice. Musgrove EA; Davison EA; Ormandy CJ J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):55-66. PubMed ID: 15082918 [TBL] [Abstract][Full Text] [Related]
39. Role of Genetic Variations in Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569 [TBL] [Abstract][Full Text] [Related]
40. [PTEN and p27Kip1 have a cooperative role on inhibition proliferation, modulation of cell cycle and inducing apoptosis in prostate cancer PC-3 cell]. Qiu Z; Sun YH; Xu CL; Wang YT; Gu ZQ; Liu Y Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):600-3. PubMed ID: 15265403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]